477
Views
31
CrossRef citations to date
0
Altmetric
Poison Centre

NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System

, &
Pages 624-628 | Received 19 Mar 2015, Accepted 15 May 2015, Published online: 11 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now

Articles from other publishers (29)

Axel Adams & Fiona E. Gallahue. 2024. Ciottone's Disaster Medicine. Ciottone's Disaster Medicine 708 711 .
Jae-Gyeong Lee, Kwang-Hyun Hur, Su-Bin Hwang, Sooyeun Lee, Seok-Yong Lee & Choon-Gon Jang. (2023) Designer Drug, 25D-NBOMe, Has Reinforcing and Rewarding Effects through Change of a Dopaminergic Neurochemical System. ACS Chemical Neuroscience 14:15, pages 2658-2666.
Crossref
Andrey V. Antsyborov. (2023) New psychoactive substances: kratom, DMT, serotonergic hallucinogens, dissociative drugs. The mechanism of action, psychoactive effects. Neurology Bulletin L:1, pages 37-43.
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Micaela Tirri, Sabrine Bilel, Raffaella Arfè, Giorgia Corli, Beatrice Marchetti, Tatiana Bernardi, Federica Boccuto, Giovanni Serpelloni, Francesco Botrè, Fabio De-Giorgio, Krystyna Golembiowska & Matteo Marti. (2022) Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs. Frontiers in Psychiatry 13.
Crossref
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Valeria Sogos, Paola Caria, Clara Porcedda, Rafaela Mostallino, Franca Piras, Cristina Miliano, Maria Antonietta De Luca & M. Paola Castelli. (2021) Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances. International Journal of Molecular Sciences 22:13, pages 6785.
Crossref
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Joel P Castellanos, Chris Woolley, Kelly Amanda Bruno, Fadel Zeidan, Adam Halberstadt & Timothy Furnish. (2020) Chronic pain and psychedelics: a review and proposed mechanism of action. Regional Anesthesia & Pain Medicine 45:7, pages 486-494.
Crossref
Katarzyna Kamińska, Paweł Świt & Kamilla Malek. (2020) 25C-NBOMe short characterisation. Forensic Toxicology 38:2, pages 490-495.
Crossref
Funda InanTibor M. Brunt, Ramon R. ContrucciLaura HondebrinkEric J. F. Franssen. (2020) Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review. Therapeutic Drug Monitoring 42:2, pages 271-281.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Joseph J. Palamar & Patricia Acosta. (2020) A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Human Psychopharmacology: Clinical and Experimental 35:1.
Crossref
Joseph J. Palamar & Austin Le. (2019) Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005–2017. Human Psychopharmacology: Clinical and Experimental 34:2, pages e2690.
Crossref
William J Scotton, Lisa J Hill, Adrian C Williams & Nicholas M Barnes. (2019) Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research 12, pages 117864691987392.
Crossref
Esther Papaseit, Magí Farré, Clara Pérez-Mañá, Marta Torrens, Mireia Ventura, Mitona Pujadas, Rafael de la Torre & Débora González. (2018) Acute Pharmacological Effects of 2C-B in Humans: An Observational Study. Frontiers in Pharmacology 9.
Crossref
Glayton A. Souza, Dilton M. Pimentel, Amanda B. Lima, Tiago J. Guedes, Luciano C. Arantes, Anderson C. de Oliveira, Raquel M. F. Sousa, Rodrigo A. A. Muñoz & Wallans T. P. dos Santos. (2018) Electrochemical sensing of NBOMes and other new psychoactive substances in blotting paper by square-wave voltammetry on a boron-doped diamond electrode. Analytical Methods 10:20, pages 2411-2418.
Crossref
Matthew Valento & Jacob Lebin. (2017) Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones. Clinical Pediatric Emergency Medicine 18:3, pages 203-211.
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Camille Richeval, Alexandra Boucher, Luc Humbert, Mélodie Phanithavong, Jean-François Wiart, Mustapha Moulsma, Antony Citterio-Quentin, Thierry Coulon, Romain Hernu, Thierry Vial, Delphine Allorge & Jean-Michel Gaulier. (2017) Retrospective identification of 25I-NBOMe metabolites in an intoxication case. Toxicologie Analytique et Clinique 29:1, pages 71-81.
Crossref
Marek Wiergowski, Justyna Aszyk, Michał Kaliszan, Kamila Wilczewska, Jacek Sein Anand, Agata Kot-Wasik & Zbigniew Jankowski. (2017) Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC–MS/MS in case of severe intoxications. Journal of Chromatography B 1041-1042, pages 1-10.
Crossref
Nicholas J. Connors & Robert S. Hoffman. 2017. Critical Care Toxicology. Critical Care Toxicology 1413 1438 .
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS) 283 311 .
Milena Majchrzak, Marcin Rojkiewicz, Rafa? Celi?ski, Piotr Ku?Mieczys?aw Sajewicz. (2015) Identification and characterization of new designer drug 4-fluoro-PV9 and ?-PHP in the seized materials. Forensic Toxicology 34:1, pages 115-124.
Crossref
Nicholas J. Connors & Robert S. Hoffman. 2016. Critical Care Toxicology. Critical Care Toxicology 1 26 .
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.